Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

AMPICILLIN TRIHYDRATE Drug Profile

« Back to Dashboard

What is the patent landscape for Ampicillin Trihydrate, and what generic alternatives are available?

Ampicillin Trihydrate is a drug marketed by Am Antibiotics, Teva, Lederle, Mylan, Purepac Pharm, Ivax Sub Teva Pharms, Dava Pharms Inc, Sandoz, and Vitarine. and is included in fifteen NDAs.

The generic ingredient in AMPICILLIN TRIHYDRATE is ampicillin/ampicillin trihydrate. Ten suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.

Summary for Tradename: AMPICILLIN TRIHYDRATE

Patents:0
Applicants:9
NDAs:15
Suppliers / Packagers: see list10
Bulk Api Vendors: see list26
Clinical Trials: see list11
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMPICILLIN TRIHYDRATE at DailyMed

Pharmacology for Tradename: AMPICILLIN TRIHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
CAPSULE;ORAL061387-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Am Antibiotics
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061601-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061370-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Dava Pharms Inc
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL062982-001Feb 10, 1989RXNoNo► Subscribe► Subscribe
Lederle
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
CAPSULE;ORAL062208-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot